8-Isoprostane Express EIA Kit

Cayman Chemical Item Number 516360

8-epi Prostaglandin F_2α Express EIA Kit; iPF_2α-III Express EIA Kit; 8-Isoprostane Express ELISA Kit; 8-iso Prostaglandin F_2α Express EIA Kit

See analysis tools…

8-Isoprostane Express EIA Kit Analysis Tools

Cayman offers a variety of analysis tools to assist you.

Learn more about analyzing your data with MyAssays.

Pre-configured for analysis on MyAssays.com

Description

Limit of detection: 80% B/B₀: 10 pg/ml · Sensitivity: 50% B/B₀: 50 pg/ml · The isoprostanes are a family of eicosanoids of non-enzymatic origin produced by the random oxidation of tissue phospholipids by oxygen radicals. Isoprostanes appear as artifacts in tissue and plasma samples which have undergone oxidative degradation during prolonged or improper storage. They also appear in the plasma and urine under normal conditions and are elevated by oxidative stress. At least one of the isoprostanes, 8-isoprostane (8-epi PGF_2α), has been shown to have biological activity. It is a potent pulmonary and renal vasoconstrictor¹ and has been implicated as a causative mediator of hepatorenal syndrome and pulmonary oxygen toxicity.² 8-Isoprostane has been proposed as a marker of antioxidant deficiency and oxidative stress and elevated levels have been found in heavy smokers.³ 8-Isoprostane levels are also a relative indicator of sample integrity for lipid-containing samples such as serum, plasma, and whole cell preparations.⁴ Plasma from healthy volunteers contains modest amounts of 8-isoprostane (40-100 pg/ml) that increase with the age of the test subject.⁵ Normal human urinary levels range from 10-50 ng/mmol creatinine, which is an order of magnitude higher than many enzymatically derived eicosanoids.^5,6 Cayman’s 8-Isoprostane Express EIA is a competitive assay that can be used for quantification of 8-isoprostane in plasma, serum, urine, whole blood, tissue culture supernatants, and other sample matrices.

1 Banerjee, M., Kang, K.H., Morrow, J.D., et al. Effects of a novel prostaglandin, 8-epi-PGF_2α, in rabbit lung in situ. Am J Physiol 263 H660-H663 (1992).

2 Vacchiano, C.A., and Tempel, G.E. Role of nonenzymatically generated prostanoid, 8-iso-PGF_2α, in pulmonary oxygen toxicity. J Appl Physiol 77 2912-2917 (1994).

3 Morrow, J.D., Frei, B., Longmire, A.W., et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 332 1198-1203 (1995).

4 Morrow, J.D., Hill, K.E., Burk, R.F., et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87 9383-9387 (1990).

5 Wang, Z., Ciabattoni, G., Créminon, C., et al. Immunological characterization of urinary 8-epi-prostaglandin F_2α excretion in man. J Pharmacol Exp Ther 275 94-100 (1995).

6 Reilly, M.P., Barry, P., Lawson, J.A., et al. Urinary 8-epi PGF_2α: An index of oxidant stress in vivo. Fibrinolysis & Proteolysis 11 81-84 (1997).

Synonyms

8-epi Prostaglandin F2α Express EIA Kit
iPF2α-III Express EIA Kit
8-Isoprostane Express ELISA Kit
8-iso Prostaglandin F2α Express EIA Kit

Stability

1 year

Storage

-20°C

Shipping

Wet ice in continental US; may vary elsewhere

Specificity

8-Isoprostane	100%
8-iso Prostaglandin F2α ethanolamide	100%
8-iso Prostaglandin F3α	20.55%
2,3-dinor-8-iso Prostaglandin F2α	4.00%
8-iso Prostaglandin E2	1.84%
2,3-dinor-8-iso Prostaglandin F1α	1.70%
8-iso Prostaglandin E1	1.56%
Prostaglandin F1α	0.71%
Prostaglandin F3α	0.66%
Prostaglandin E1	0.39%
Prostaglandin D2	0.16%
6-keto Prostaglandin F1α	0.14%
Prostaglandin F2α	0.14%
2,3-dinor-6-keto Prostaglandin F1α	0.09%
8-iso Prostaglandin F1β	0.08%
Thromboxane B2	0.08%
11-dehydro Thromboxane B2	0.07%
11β-Prostaglandin F2α	0.03%
Prostaglandin E2	0.02%
8-iso-15(R)-Prostaglandin F2α	0.02%
8,12-epi iPF2α-III	<0.01%
iPF2α-III	<0.01%
8,12-epi iPF2α-VI	<0.01%
tetranor-PGEM	<0.01%
tetranor-PGFM	<0.01%
13,14-dihydro-15-keto Prostaglandin F2α	<0.01%

Show all 26 Hide all but first 3

Background Reading

Banerjee, M., Kang, K.H., Morrow, J.D., et al. Effects of a novel prostaglandin, 8-epi-PGF_2α, in rabbit lung in situ. Am J Physiol 263 H660-H663 (1992).

Vacchiano, C.A., and Tempel, G.E. Role of nonenzymatically generated prostanoid, 8-iso-PGF_2α, in pulmonary oxygen toxicity. J Appl Physiol 77 2912-2917 (1994).

Morrow, J.D., Frei, B., Longmire, A.W., et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 332 1198-1203 (1995).

Morrow, J.D., Hill, K.E., Burk, R.F., et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87 9383-9387 (1990).

Wang, Z., Ciabattoni, G., Créminon, C., et al. Immunological characterization of urinary 8-epi-prostaglandin F_2α excretion in man. J Pharmacol Exp Ther 275 94-100 (1995).

Reilly, M.P., Barry, P., Lawson, J.A., et al. Urinary 8-epi PGF_2α: An index of oxidant stress in vivo. Fibrinolysis & Proteolysis 11 81-84 (1997).

Maclouf, J., Grassi, J., and Pradelles, P. Development of enzyme-immunoassay techniques for the measurement of eicosanoids. 355-364 (1987).

Pradelles, P., Grassi, J., and Maclouf, J. Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol 187 24-34 (1990).

Morrow, J.D., Harris, T.M., and Roberts, L.J. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal Biochem 184 1-10 (1990).

Maxey, K.M., Maddipati, K.R., and Birkmeier, J. Interference in enzyme immunoassays. J Clin Immunoassay 15 116-120 (1992).

Show all 10 Hide all but first 3

516360-480well

8-Isoprostane Express EIA Kit

8-Isoprostane Express EIA Kit

8-Isoprostane Express EIA Kit Analysis Tools

Description

Background Reading

Related Products

Downloads

Batch-specific Information

Quick Search